Medical Devices: Technological Innovation and Patient/Provider Perspectives: Hearing Before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, First Session, May 30, 1997
U.S. Government Printing Office, 1997 - Political Science - 86 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
agency Alpert applications approval process Barton benefit Bilbray Bilirakis brain breast cancer breast implants Burlington Burr cadaver skin CDRH Chairman clinical trials Congress consumers Deep Brain Stimulation Dermagraft-TC developed DIANA DeGETTE doctors dopamine dramatic Eshoo FDA approval FDA reform FDA's fibroblasts Friedman Ganske globus pallidus going Hansbrough hearing heart HUGH DOWNS implantable defibrillator important improve innovative issue labeling levodopa look mammograms mammography manufacturers medical devices national uniformity OTC drugs pacemaker pallidotomy Parkinson's disease patients PDUFA percent performance physicians premarket approval Prepared Statement prescription drugs problems procedure question radiologists regulation regulatory require risk safe and effective safety side effects stents studies Stupak subcommittee subthalamic nucleus sudden death surgery surgical switch drugs testimony therapy things tients tion tissue treatment user fees Vaas Warren Olanow Waxman Whitfield